0001415889-23-004107.txt : 20230303 0001415889-23-004107.hdr.sgml : 20230303 20230303161829 ACCESSION NUMBER: 0001415889-23-004107 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Turitz Andrew CENTRAL INDEX KEY: 0001726221 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 23704254 MAIL ADDRESS: STREET 1: C/O TELADOC, INC. STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 form4-03032023_090316.xml X0306 4 2023-03-01 0001477449 Teladoc Health, Inc. TDOC 0001726221 Turitz Andrew C/O TELADOC HEALTH, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 false true false false SVP - CORPORATE DEVELOPMENT Common Stock 2023-03-01 4 M 0 5389 A 20183 D Common Stock 2023-03-02 4 S 0 1801 25.362 D 18382 D Common Stock 2023-03-02 4 M 0 1205 A 19587 D Common Stock 2023-03-02 4 M 0 2048 A 21635 D Common Stock 2023-03-02 4 M 0 515 A 22150 D Common Stock 2023-03-02 4 M 0 1147 A 23297 D Common Stock 2023-03-02 4 M 0 867 A 24164 D Common Stock 2023-03-02 4 M 0 437 A 24601 D Restricted Stock Units 2023-03-01 4 M 0 5389 0 D Common Stock 5389 10781 D Restricted Stock Units 2023-03-02 4 M 0 1205 0 D Common Stock 1205 0 D Performance Stock Units 2023-03-02 4 M 0 2048 0 D Common Stock 2048 0 D Performance Stock Units 2023-03-02 4 M 0 515 0 D Common Stock 515 0 D Restricted Stock Units 2023-03-02 4 M 0 1147 0 D Common Stock 1147 1148 D Performance Stock Units 2023-03-02 4 M 0 867 0 D Common Stock 867 867 D Performance Stock Units 2023-03-02 4 A 0 874 0 A Common Stock 874 874 D Performance Stock Units 2023-03-02 4 M 0 437 0 D Common Stock 437 437 D Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Performance stock units convert to shares of TDOC common stock on a one-for-one basis On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. On March 2, 2022, the reporting person earned 1,030 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Each performance stock unit represents a contingent right to receive one share of TDOC common stock. Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022. The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. /s/ Adam C. Vandervoort, Attorney-in-Fact 2023-03-03